An observational study in Dental Caries and Caries Risk, sponsored by October University for Modern Sciences and Arts. Recruiting at 1 site in Egypt. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-21.
Sponsored by October University for Modern Sciences and Arts · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 206 studies in Dental Caries with a site in Egypt — 47 open to participants now, 67 under way, 1 of them phase 3. Dental Caries · Egypt.
Among the 206 studies in Dental Caries with a site in Egypt, this one is the 6th largest by planned enrollment of the 27 observational ones that give a count, is one of 13 that started in 2026, is one of 27 observational ones, reaches primary completion later than 45 of the 66 other live ones, and was the 194th registered.
1,175 studies on the registry are indexed under Dental Caries; 209 are open to participants now.
Browse Dental Caries studies →47 of the 206 studies in Dental Caries with a site in Egypt are open now. Recruiting first, the newest first:
Minia University · Sites in Egypt
Ages 8–10
Mansoura University · Sites in Egypt
Ages 15–20
Assiut University · Sites in Egypt
Ages 3–8
Mansoura University · Sites in Egypt
Ages 6–9
Mansoura University · Sites in Egypt
Ages 14–26
A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →
Of the 86 Dental Caries studies recruiting now, 18 (21%) set no upper age limit and 66 (77%) stop at 75 or younger; 60 take children under 18; 53 take healthy volunteers.
This study: 18 Years to 65 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
206 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 4 · Phase 2 8 · Phase 3 8 · Phase 4 9
First in 2011; this study’s year is marked. 13 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 384 is above the median of 169 across 191 observational studies indexed under Dental Caries.
Median enrollment 44 across the 179 interventional studies, 204 across the 27 observational. Of the 104 that completed or were terminated, 2 (2%) have results posted.
This tab as a report to print or save as PDF → With an account.
2 of 206 have an industry lead sponsor. The 10 most frequent:
October University for Modern Sciences and Arts is the lead sponsor of 52 studies on the registry; 20 are open to participants now.
October University for Modern Sciences and Arts has 3 studies filed under Dental Caries — fewer than ten, so there is no comparison to draw.
18 of the studies in Dental Caries with a site in Egypt that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07786805Tanta UniversityBite Force Recovery Following Pediatric Full Crown Restorations | 2026-11 |
| NCT05943782Ain Shams UniversityEvaluation of CAD/CAM Onlays Fabricated by Subtractive Versus Additive Digital Manufacturing Techniques. | 2026-12-01 |
| NCT07612540Cairo UniversityRetention and Caries Prevention of Giomer Sealant With or Without Diode Laser Pre-treatment: A Randomized Controlled Trial | 2026-12-01 |
| NCT07262086Suez Canal UniversityClinical Evaluation of Wear Resistance and Bioactivity of Self Cured Bioactive Resin Composite | 2026-12-02 |
| NCT07711132Mansoura UniversityRemineralizing Effect of Nano-eggshell, Casein Phosphopeptide Amorphous Calcium Phosphate (CPP-ACP), and Sodium Fluoride on Initial Enamel Caries | 2026-12-20 |
Add all 18 to your calendar (.ics) → With an account.
Among the 206 studies in Dental Caries with a site in Egypt, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study is designed as a cross-sectional diagnostic agreement study conducted in accordance with the Standards for Reporting Diagnostic Accuracy Studies (STARD 2015) and the Guidelines for Reporting Agreement and Precision of Patient-reported Assessments (GRAPPA). The study evaluates the diagnostic agreement between the Digital Caries Risk Questionnaire (DCRQ), a novel patient self-administered digital instrument, and the Caries Management by Risk Assessment (CAMBRA) protocol as the primary clinical comparator. The Decayed, Missing, and Filled Teeth (DMFT) index is used as the reference standard for cumulative caries experience, with a threshold of DMFT ≥ 4 to identify individuals with high caries experience. Although the DMFT index reflects previous disease experience rather than future disease risk, it provides an objective clinical outcome for assessing construct validity. Accordingly, CAMBRA serves as the primary comparator for risk classification, whereas the DMFT index supports validation by evaluating the relationship between questionnaire-derived risk categories and cumulative clinical disease burden.
The methodological rationale for this study is based on the current evidence supporting contemporary caries risk assessment models. CAMBRA is recognized as one of the most extensively validated and widely implemented caries risk assessment systems and has demonstrated diagnostic performance comparable to other internationally accepted risk assessment models. Systematic evidence has shown that these validated models provide acceptable discriminatory ability and calibration for identifying individuals at increased risk of developing dental caries. Furthermore, recent evidence synthesizing longitudinal cohort studies has identified a consistent set of adult caries risk factors, including smoking, systemic diseases, water fluoridation exposure, educational level, fluoride toothpaste use, dietary sugar intake, bacterial plaque accumulation, and previous caries experience. These established determinants are comprehensively represented within the nine domains of the DCRQ, supporting its content validity. In addition, previous validation studies of simplified questionnaire-based caries risk assessment instruments have demonstrated acceptable internal consistency, good test-retest reliability, and significant associations between increasing risk categories and objective clinical indicators such as DMFT scores, plaque accumulation, white spot lesions, and active cavitated lesions. Collectively, these findings support the use of a cross-sectional diagnostic agreement design in which questionnaire-derived risk classification is evaluated against an established clinical risk assessment protocol and validated using objective measures of cumulative caries experience.
The study will be conducted at the Dental Outpatient Clinic, Faculty of Dentistry, MSA University (October University for Modern Sciences and Arts), 6th October City, Cairo, Egypt. Consecutive sampling will be employed on designated study days to minimise selection bias, consistent with STARD 2015 recommendations for diagnostic accuracy studies.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Adults aged 18 to 65 years.
Presence of acute dental pain or a dental emergency requiring immediate treatment at the time of enrollment.
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Diagnostic Test: Digital Caries Risk Assessment
The Digital Caries Risk Questionnaire (DCRQ) is a patient self-administered digital instrument encompassing nine weighted risk domains: (1) disease indicators and dental history; (2) dietary and lifestyle habits; (3) oral hygiene practices and fluoride use; (4) salivary and gingival health; (5) medical conditions; (6) current medications; (7) water source and fluoride exposure; (8) tobacco and nicotine use; and (9) clinical symptoms. Each domain generates a weighted subscore; domain scores are summed to yield a total score (maximum 160 points), with predefined override rules applied to prevent underestimation of risk in participants presenting with strong disease indicators (e.g., multiple restorations, root canal treatments, or persistent dental pain), ensuring clinically appropriate classification regardless of total score. The total score maps to one of four ordered risk categories: Low (0-39), Moderate (40-79), High (80-119), and Very High (120-160).
Cohen's weighted kappa
The primary outcome is Cohen's weighted kappa (κw) with quadratic weights, computed between DCRQ and CAMBRA 4-level classifications (Low / Moderate / High / Very High). Both instruments share a 4-tier structure; no category collapsing is required. Minimum acceptable agreement: κw ≥ 0.41 (lower bound of 95% CI), corresponding to moderate agreement per Landis and Koch (1977). The 95% CI will be computed by bootstrap resampling (2,000 iterations).
Time frame: Baseline (single study visit)
Diagnostic accuracy of the Digital Caries Risk Questionnaire (DCRQ) for identifying participants with high cumulative caries experience (DMFT ≥ 4).
Diagnostic accuracy will be evaluated by calculating sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) using DMFT ≥ 4 as the reference standard.
Time frame: Baseline (single study visit)
Discriminative ability of the DCRQ for identifying participants with high cumulative caries experience.
Receiver operating characteristic (ROC) curve analysis will be performed to determine the area under the curve (AUC) and the optimal DCRQ score cut-off for predicting DMFT ≥ 4.
Time frame: Baseline (single study visit)
Independent predictors of high cumulative caries experience.
Multivariable logistic regression will be used to identify independent predictors of DMFT ≥ 4 and estimate the contribution of each DCRQ domain after adjustment for relevant covariates.
Time frame: Baseline (single study visit)
Internal consistency of the DCRQ.
Internal consistency reliability will be assessed using Cronbach's alpha coefficient.
Time frame: Baseline (single study visit)
Test-retest reliability of the DCRQ.
Test-retest reliability will be assessed using the intraclass correlation coefficient (ICC) in a nested subset of 60 participants who complete the DCRQ on two occasions separated by a 14-day interval.
Time frame: 14 days after baseline
Performance of the DCRQ across participant subgroups.
Diagnostic performance and agreement of the DCRQ will be evaluated according to age, sex, educational level, and smoking status.
Time frame: Baseline (single study visit)
Plan to share: Undecided
Started Jun 2026 (actual). Primary completion is estimated for Oct 2026, 3 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
October University for Modern Sciences and Arts